Aarti Drugs Limited reported audited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, standalone net sales were INR 2,634.6 million compared with INR 2,529.7 million for the same period last year. Profit from operation before other income, financial cost and exceptional items was INR 309.4 million compared with INR 334.4 million for the same period last year. Profit from ordinary activities before tax was INR 223.4 million compared with INR 223.6 million for the same period last year. Net profit for the period was INR 163.4 million or INR 6.75 basic and diluted per share as compared with net profit for the period of INR 156.1 million or INR 6.86 basic and diluted per share for the same period last year. For the nine months, standalone net sales were INR 8,191.1 million compared with INR 7,737.8 million for the same period last year. Profit from operation before other income, financial cost and exceptional items was INR 1,038.8 million compared with INR 1,014.5 million for the same period last year. Profit from ordinary activities before tax was INR 774.8 million compared with INR 694.2 million for the same period last year. Net profit for the period was INR 537.8 million or INR 22.21 basic and diluted per share as compared with net profit for the period of INR 491.7 million or INR 20.31 basic and diluted per share for the same period last year. For the quarter, on consolidated basis, net sales were INR 2,896.6 million compared with INR 2,649.9 million for the same period last year. Profit from operation before other income, financial cost and exceptional items was INR 331.9 million compared with INR 339.3 million for the same period last year. Profit from ordinary activities before tax was INR 240.9 million compared with INR 227.8 million for the same period last year. Net profit for the period was INR 178.5 million or INR 7.38 basic and diluted per share as compared with net profit for the period of INR 170.3 million or INR 7.03 basic and diluted per share for the same period last year. For the nine months, standalone net sales were INR 8,962.7 million compared with INR 8,209.2 million for the same period last year. Profit from operation before other income, financial cost and exceptional items was INR 1,131 million compared with INR 1,027.6 million for the same period last year. Profit from ordinary activities before tax was INR 852.6 million compared with INR 703.8 million for the same period last year. Net profit for the period was INR 598.6 million or INR 24.73 basic and diluted per share as compared with net profit for the period of INR 501.3 million or INR 20.70 basic and diluted per share for the same period last year.